drugset / Trial / NCT01009697

Dose Linearity Study of Codeine Sulfate Under Fasted Conditions

NCT01009697

Phase 1 Completed 34 enrolled Roxane Laboratories
RandomizedCrossoverOpen-labelTreatment

Summary

The objective of this study was to examine the dose linearity of Roxane Laboratories' 15 mg, 30 mg, and 60 mg codeine sulfate tablets under fasted conditions

Timeline

Start
2008-03
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Codeine Small molecule 15 mg
Subject Codeine Small molecule 30 mg
Subject Codeine Small molecule 60 mg

Indications

No indication recorded.